Gilead Sciences, Inc.
GILDFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
28,754
Cost of Revenue
6,251
Gross Profit
22,503
Gross Margin
78.3%
Operating Income
1,662
Operating Margin
5.8%
Net Income
480
Net Margin
1.7%
EPS (Basic)
$0.38
EPS (Diluted)
$0.38
EBITDA
4,434
EBITDA Margin
15.4%
2023
12/31/2023
Revenue
27,116
Cost of Revenue
6,498
Gross Profit
20,618
Gross Margin
76.0%
Operating Income
7,605
Operating Margin
28.0%
Net Income
5,665
Net Margin
20.9%
EPS (Basic)
$4.54
EPS (Diluted)
$4.50
EBITDA
10,496
EBITDA Margin
38.7%
2022
12/31/2022
Revenue
27,281
Cost of Revenue
5,657
Gross Profit
21,624
Gross Margin
79.3%
Operating Income
7,330
Operating Margin
26.9%
Net Income
4,592
Net Margin
16.8%
EPS (Basic)
$3.66
EPS (Diluted)
$3.64
EBITDA
8,852
EBITDA Margin
32.4%
2021
12/31/2021
Revenue
27,305
Cost of Revenue
6,601
Gross Profit
20,704
Gross Margin
75.8%
Operating Income
9,918
Operating Margin
36.3%
Net Income
6,225
Net Margin
22.8%
EPS (Basic)
$4.96
EPS (Diluted)
$4.93
EBITDA
11,329
EBITDA Margin
41.5%
2020
12/31/2020
Revenue
24,689
Cost of Revenue
4,572
Gross Profit
20,117
Gross Margin
81.5%
Operating Income
4,071
Operating Margin
16.5%
Net Income
123
Net Margin
0.5%
EPS (Basic)
$0.10
EPS (Diluted)
$0.10
EBITDA
4,133
EBITDA Margin
16.7%